DK21889A - Anvendelse af monacolin k, den tilsvarende carboxylsyreforbindelse eller salte af carboxylsyren til fremstilling af et laegemiddel til behandling af hypercholesterolaemi - Google Patents

Anvendelse af monacolin k, den tilsvarende carboxylsyreforbindelse eller salte af carboxylsyren til fremstilling af et laegemiddel til behandling af hypercholesterolaemi

Info

Publication number
DK21889A
DK21889A DK021889A DK21889A DK21889A DK 21889 A DK21889 A DK 21889A DK 021889 A DK021889 A DK 021889A DK 21889 A DK21889 A DK 21889A DK 21889 A DK21889 A DK 21889A
Authority
DK
Denmark
Prior art keywords
carboxylic acid
monacolin
medicine
salts
preparation
Prior art date
Application number
DK021889A
Other languages
English (en)
Other versions
DK21889D0 (da
Inventor
Akira Endo
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of DK21889D0 publication Critical patent/DK21889D0/da
Publication of DK21889A publication Critical patent/DK21889A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/30—Oxygen atoms, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14—Fungi; Culture media therefor
    • C12N1/145—Fungi isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/02—Oxygen as only ring hetero atoms
    • C12P17/06—Oxygen as only ring hetero atoms containing a six-membered hetero ring, e.g. fluorescein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/645—Fungi ; Processes using fungi

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Virology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
DK021889A 1979-02-20 1989-01-18 Anvendelse af monacolin k, den tilsvarende carboxylsyreforbindelse eller salte af carboxylsyren til fremstilling af et laegemiddel til behandling af hypercholesterolaemi DK21889A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP54017856A JPS5925599B2 (ja) 1979-02-20 1979-02-20 新生理活性物質モナコリンｋおよびその製造法

Publications (2)

Publication Number Publication Date
DK21889D0 DK21889D0 (da) 1989-01-18
DK21889A true DK21889A (da) 1989-01-18

Family

ID=11955290

Family Applications (2)

Application Number Title Priority Date Filing Date
DK73080A DK149095C (da) 1979-02-20 1980-02-20 Fremgangsmaade til fremstilling af en cholesterolsynteseinhiberende forbindelse kaldet monacolin k
DK021889A DK21889A (da) 1979-02-20 1989-01-18 Anvendelse af monacolin k, den tilsvarende carboxylsyreforbindelse eller salte af carboxylsyren til fremstilling af et laegemiddel til behandling af hypercholesterolaemi

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK73080A DK149095C (da) 1979-02-20 1980-02-20 Fremgangsmaade til fremstilling af en cholesterolsynteseinhiberende forbindelse kaldet monacolin k

Country Status (27)

Country Link
JP (1) JPS5925599B2 (da)
KR (1) KR830002801B1 (da)
AT (1) AT373915B (da)
AU (1) AU532626B2 (da)
BE (1) BE881825A (da)
CA (1) CA1129794A (da)
CH (1) CH645890A5 (da)
DD (1) DD154494A5 (da)
DE (2) DE3051175C2 (da)
DK (2) DK149095C (da)
ES (1) ES8103171A1 (da)
FI (1) FI66427C (da)
FR (1) FR2449685B1 (da)
GB (1) GB2046737B (da)
HU (1) HU182069B (da)
IE (1) IE49743B1 (da)
IT (1) IT1175260B (da)
MX (1) MX6314E (da)
NL (1) NL191540C (da)
NO (1) NO153974C (da)
NZ (1) NZ192919A (da)
PH (1) PH15145A (da)
PL (1) PL124304B1 (da)
SE (1) SE453301B (da)
SG (1) SG6784G (da)
SU (2) SU1158048A3 (da)
ZA (1) ZA80962B (da)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55150898A (en) * 1979-05-11 1980-11-25 Sankyo Co Ltd Preparation of a new physiologically active substance mb-530b
US4231938A (en) * 1979-06-15 1980-11-04 Merck & Co., Inc. Hypocholesteremic fermentation products and process of preparation
JPS5621594A (en) * 1979-07-27 1981-02-28 Sankyo Co Ltd Mb-530b carboxylic acid metal salt and its preparation
PT72394B (en) * 1980-02-04 1982-09-06 Merck & Co Inc Process for preparing dihydro and tetrahydromevinoline hypocholesterolimics
AU548996B2 (en) * 1980-02-04 1986-01-09 Merck & Co., Inc. Tetrahydro-2h-pyran-2-one derivatives
JPH0692381B2 (ja) * 1980-03-31 1994-11-16 三共株式会社 Ｍｂ−５３０ａ誘導体
JPS56142236A (en) 1980-04-08 1981-11-06 Sankyo Co Ltd Ml-236a and mb-530a derivative
DK149080C (da) * 1980-06-06 1986-07-28 Sankyo Co Fremgangsmaade til fremstilling af derivater af ml-236b-carboxylsyre
JPS5835144A (ja) * 1981-08-27 1983-03-01 Sankyo Co Ltd Ｍｂ−５３０ｂ誘導体およびその製造法
US4782084A (en) * 1987-06-29 1988-11-01 Merck & Co., Inc. HMG-COA reductase inhibitors
US4997848A (en) * 1987-10-27 1991-03-05 Sankyo Company, Limited Octahydronaphthalene oxime derivatives for cholesterol synthesis inhibition
CA2062023A1 (en) * 1992-02-10 1993-08-11 Jagroop S. Dahiya Novel fungal strains and use thereof in antibiotic production
JPH07504568A (ja) * 1992-03-04 1995-05-25 藤沢薬品工業株式会社 ＨＭＧ−ＣｏＡレダクターゼ阻害物質としてのテトラリン誘導体
FI932188L (fi) 1992-05-15 1993-11-16 Sankyo Co Oktahydronaftalenoximderivat foer inhibering av kolesterolbiosyntesen, deras framstaellning och anvaendning
HU210867B (en) * 1992-11-04 1995-10-30 Biogal Gyogyszergyar Method for extraction and purification of mevinolin from culture medium
US6812007B1 (en) * 1992-11-04 2004-11-02 Keri Vilmos Process for the isolation and purification of mevinolin
SI9300303A (en) * 1993-06-08 1994-12-31 Krka Tovarna Zdravil Process for isolation of hypolipemic effective substance
US5409820A (en) * 1993-08-06 1995-04-25 Apotex, Inc. Process for the production of lovastatin using Coniothyrium fuckelii
US7238348B2 (en) 1996-09-30 2007-07-03 Beijing Peking University Wbl Corporation Ltd. Method of treatment of osteoporosis with compositions of red rice fermentation products
US6046022A (en) 1996-09-30 2000-04-04 Peking University Methods and compositions employing red rice fermentation products
US6500651B1 (en) 1998-03-20 2002-12-31 Biogal Gyogyszergyar Rt. Metabolic controlled fermentation procedure for the manufacture of lovastatin hydroxy acid
AU2001236543B2 (en) 2000-02-24 2005-02-03 Teva Gyogyszergyar Reszvenytarsasag Method of purifying a fermentation broth
TR200403001T3 (tr) 2000-03-03 2005-02-21 Plus Chemical, S.A. Lovastatin ve simvastatinin, azaltılmış dimerik katışkı seviyelerine sahip olacak şekilde arıtılması için bir işlem
KR20010095780A (ko) * 2000-04-12 2001-11-07 나가오카 마사시 배아 홍국
IN192861B (da) 2000-06-30 2004-05-22 Ranbaxy Lab Ltd
AU2002235885A1 (en) * 2001-02-09 2002-08-28 Unilever N.V. Process for the preparation of one or more statins by fermentation
KR100379075B1 (en) 2002-03-07 2003-04-08 Jinis Biopharmaceuticals Co Method for producing low cholesterol animal food product and food product therefrom
KR20020093147A (ko) * 2002-05-30 2002-12-13 지니스생명공학 주식회사 성인병 예방 및 치료 보조제
KR100710500B1 (ko) 2005-05-18 2007-04-24 고려대학교 산학협력단 홍국균을 이용한 모나콜린 ｋ 생산방법
SI2373609T1 (sl) 2008-12-19 2013-12-31 Krka, D.D., Novo Mesto Uporaba amfifilnih spojin za kontrolirano kristalizacijo statinov in intermediatov statinov
EP2327682A1 (en) 2009-10-29 2011-06-01 KRKA, D.D., Novo Mesto Use of amphiphilic compounds for controlled crystallization of statins and statin intermediates
RO128803A0 (ro) 2012-10-12 2013-09-30 Ion Gigel Fulga Compoziţie pentru tratamentul sau prevenirea dislipidemiilor
CN110331151A (zh) * 2019-04-11 2019-10-15 北京工商大学 紫色红曲菌mokH基因过表达菌株的构建方法
CN111297938A (zh) * 2020-03-11 2020-06-19 北京康立生医药技术开发有限公司 一种辅助降血脂组合物中洛伐他汀的检测方法
JP2022135089A (ja) * 2021-03-04 2022-09-15 小林製薬株式会社 コレステロールの低減剤

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5612114B2 (da) * 1974-06-07 1981-03-18
JPS55150898A (en) * 1979-05-11 1980-11-25 Sankyo Co Ltd Preparation of a new physiologically active substance mb-530b
IL60219A (en) * 1979-06-15 1985-05-31 Merck & Co Inc Hypocholesteremic fermentation products of the hmg-coa reductase inhibitor type,their preparation and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
ES488796A0 (es) 1981-02-16
IE800321L (en) 1980-08-20
NO153974B (no) 1986-03-17
NO800451L (no) 1980-08-21
SE453301B (sv) 1988-01-25
MX6314E (es) 1985-04-01
GB2046737B (en) 1983-01-12
PH15145A (en) 1982-08-24
DE3051175C2 (da) 1989-12-21
SG6784G (en) 1985-02-08
NL191540C (nl) 1995-09-04
DK73080A (da) 1980-08-21
NO153974C (no) 1986-06-25
GB2046737A (en) 1980-11-19
FI66427B (fi) 1984-06-29
DE3006216C2 (de) 1985-10-31
HU182069B (en) 1983-12-28
JPS55111790A (en) 1980-08-28
DK21889D0 (da) 1989-01-18
AT373915B (de) 1984-03-12
IT1175260B (it) 1987-07-01
NZ192919A (en) 1984-07-06
FR2449685B1 (fr) 1985-06-28
KR830002030A (ko) 1983-05-21
NL191540B (nl) 1995-05-01
PL124304B1 (en) 1983-01-31
JPS5925599B2 (ja) 1984-06-19
ES8103171A1 (es) 1981-02-16
FI66427C (fi) 1984-10-10
FR2449685A1 (fr) 1980-09-19
SU1158048A3 (ru) 1985-05-23
SE8001339L (sv) 1980-08-21
IE49743B1 (en) 1985-12-11
ATA92980A (de) 1983-07-15
DE3006216A1 (de) 1980-09-04
AU532626B2 (en) 1983-10-06
BE881825A (fr) 1980-08-20
CH645890A5 (de) 1984-10-31
DK149095C (da) 1986-06-16
SU969702A1 (ru) 1982-10-30
AU5567380A (en) 1980-08-28
ZA80962B (en) 1981-03-25
DK149095B (da) 1986-01-20
IT8067262A0 (it) 1980-02-20
PL222120A1 (da) 1980-10-20
CA1129794A (en) 1982-08-17
NL8001041A (nl) 1980-08-22
KR830002801B1 (ko) 1983-12-16
FI800506A7 (fi) 1980-08-21
DD154494A5 (de) 1982-03-24

Similar Documents

Publication Publication Date Title
DK21889A (da) Anvendelse af monacolin k, den tilsvarende carboxylsyreforbindelse eller salte af carboxylsyren til fremstilling af et laegemiddel til behandling af hypercholesterolaemi
DK160099C (da) Analogifremgangsmaade til fremstilling af optisk aktive eller racemiske 6-substituerede 2-penem-3-carboxylsyreforbindelser eller farmaceutisk anvendelige salte deraf
DK151884C (da) Analogifremgangsmaade til fremstilling af 3-(1-imidazolylalkyl)indolderivater eller farmaceutisk acceptable syreadditionssalte deraf
DK151623C (da) Analogifremgangsmaade til fremstilling af n-substituerede moranolinderivater eller farmaceutisk acceptable syreadditionssalte deraf
NO155055C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive beta-carbolin-3-carboxylsyrederivater.
NO150106C (no) Anvendelse av en n-acyl-alfa-aminosyre som emulgeringsmiddel for fremstilling av emulsjoner
DK145376C (da) Analogifremgangsmaade til fremstilling af n-(1'-benzyl-2'-pyrrolidinylmethyl)-benzamider eller syreadditionssalte,kvaternaere ammoniumsalte eller optisk aktive isomere deraf
DK149569C (da) Analogifremgangsmaade til fremstilling af isoquinolineddikesyre-forbindelser eller farmaceutisk acceptable salte deraf
DK125179A (da) Fremgangsmaade til fremstilling af disubstituerede 3-cephem-4-catboxylsyrederivater
DK322380A (da) Fr&mgangsmaade til fremstilling af monacolin k salte eller estere
DK335279A (da) Fremgangsmaade til fremstilling af spirofuranohydantoin-forbindelser eller farmaceutisk acceptable metalsalte deraf
AR219859A1 (es) Procedimiento para la eliminacion de acido ascorbico a partir de soluciones acuosas
NO152089C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 4-pyridon-3-karboksylsyrederivater
DK321482A (da) Fremgangsmaade til fremstilling af 1-imidazolyl-2-phenyl-8-piperazinylphenoxy-octan-2-ol-forbindelser eller farmaceutisk acceptable syreadditionssalte deraf
DK165005C (da) Analogifremgangsmaade til fremstilling af 4,5-dihydro-4-oxofuran-2-carboxylsyrederivater eller terapeutisk acceptable salte deraf
DK430379A (da) Fremgangsmaade til fremstilling af 2,6-diaminonebulariner eller syreadditionssalte deraf
DK152427C (da) Analogifremgangsmaade til fremstilling af 4-thiomethylpyridinforbindelser eller farmaceutisk acceptable syreadditionssalte deraf
DK160874C (da) Analogifremgangsmaade til fremstilling af ergol-8-en- eller ergolinforbindelser eller farmaceutisk acceptable syreadditionssalte deraf
DK157021C (da) Analogifremgangsmaade til fremstilling af 2,3-polymethylen-4-oxo-4h-pyrido- eller -azepinooe1,2-aaapyrimidiner eller farmaceutisk acceptable syreadditionssalte eller kvaternaere salte deraf
RO81506A (ro) Procedeu pentru prepararea derivatilor acizilor 1,3,4-tiadiazol-2-carboxilici
DK148036C (da) Analogifremgangsmaade til fremstilling af epimere 4''-amino-erythromycin-forbindelser eller syreadditionssalte deraf
DK317678A (da) Fremgangsmaade til fremstilling af 3-(1-pyrazolyl)-pyridazindf erivater eller farmaceutisk acceptable syreaddtionssalte dera
DK153539C (da) Fremgangsmaade til fremstilling af 3,3-dimethyl-2-oxosmoersyre eller salte deraf
DK516480A (da) Fremgangsmaade til fremstilling af 2-amino-ethanol-derivater eller syreadditionssalte deraf
FI792548A7 (fi) Fenyyliguanidiinisulfonihappoesterien monokarboksylaatteja, menetelmiä niiden valmistamiseksi ja niiden käytlääkeianeina.

Legal Events

Date Code Title Description
ARF Application refused